Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 8,182 shares at $19.79 ($162K) on 2026-01-20, disclosed to the SEC on 2026-01-21.
Seasonal sale ($162k) by Chief Executive Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |
| APLS | SELL | 2025-07-16 | $5.6M | — | Filing → |